Evidence map›Paper›PMID 35219803›Full record

ArticleJournal of clinical epidemiology2022

Coronavirus disease 2019 scenarios for a long-term strategy under fundamental uncertainty.

Frans Brom, Josta de Hoog, J André Knottnerus, Ruth Mampuys, Tanja van der Lippe

Abstract read
In one paragraph

Article in Journal of clinical epidemiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Editors' Choice: August 2022.Journal of clinical epidemiology · 2022
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Frans BromScientific Council for Government Policy (WRR) and Professor of Normative Aspects of Scientific Policy Advice at Utrecht University, The Hague, The Netherlands.
Josta de HoogNetherlands Scientific Council for Government Policy (WRR) The Hague, The Netherlands.
J André KnottnerusMaastricht University, Former Chair Netherlands Scientific Council for Government Policy (WRR) and former Chair of the Health Council of the Netherlands Maastricht, The Netherlands. Electronic address: andre.knottnerus@maastrichtuniversity.nl.
Ruth MampuysScientific Council for Government Policy (WRR), The Hague, The Netherlands.
Tanja van der LippeSociology at Utrecht University, Chair of the Social Sciences Council of The Royal Netherlands Academy of Arts and Sciences (KNAW), Utrecht, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early on, scientists have pointed out that coronavirus disease 2019 is most likely here to stay, although its course and development are uncertain. This requires a long-term strategy of living with the virus. However, the urgency of new waves of infection and the emergence of new variants have invoked an approach of acute crisis management over and over, hindering the design of a structural approach for the long term. Exploratory scenarios can provide scientific strategic guidance to policy processes to be better prepared in this situation of fundamental uncertainty. We have therefore developed five scenarios, which describe the possible long-term development of the pandemic from an epidemiological, virological, and broader societal perspective. These scenarios are based on four driving forces that are both important and uncertain: immunity, vaccination, mutations, and human behavior. The scenarios are (1) return to normal, (2) flu+, (3) external threat, (4) continuous struggle, and (5) worst case. Working with scenarios is crucial for appropriate public communication and provides guidance for anticipating the various conceivable possibilities for the further course of the pandemic.

Indexed as

COVID-19PhysiciansHumansPandemicsUncertaintyVaccinationAnticipationChessCommunicationCourseCOVID-19DevelopmentDriving forcesExploratory scenariosHuman behaviorImmunityLong-termMutationsPandemicPolicyPreparednessScientific guidanceStrategyUncertaintyVaccinationVirus variants

Identifiers

PMID35219803
PMCPMC8873039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.